The effect of early life cytomegalovirus infection on the immune profile of children
Clinical Immunology · 2024
DOI: 10.1016/j.clim.2024.110330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2024. Verfasst von Ilse Ekman und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, CD8-Positive T-Lymphocytes, CD4-Positive T-Lymphocytes. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, Sigrid Jusélius Foundation.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Cytomegalovirus (CMV) infection has a life-long impact on the immune system, particularly on memory T cells. However, the effect of early life CMV infection on the phenotype and functionality of T cells in infants and especially longitudinal changes occurring during childhood have not been explored in detail. The phenotype and functionality of peripheral blood CD8+ and CD4+ T cells from children infected with CMV in early life (< 6 months of age) was analyzed using high-dimensional flow cytometry. Samples from CMV IgG-seropositive (CMV+) children were collected at 6 months and 6 years of age and compared to samples from CMV-seronegative (CMV-) children. Early life CMV infection caused multiple alterations within T cells. These include downregulation of CD28 expression and upregulation of CD57 expression within both CD27+ early and CD27- late effector memory CD8+ and CD4+ T-cells at 6 months of age. Of these changes, only alterations within the highly differentiated late effector memory compartment persisted at the age of 6 years. Early life CMV-infection has a distinct impact on developing CD8+ and CD4+ memory T cell compartments. It appears to induce both temporary as well as longer-lasting alterations, which may affect the functionality of the immune system throughout life.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Microbiology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
- Institute of Biomedicine, University of Turku, Turku, Finland; Department of Clinical Microbiology, Turku University Hospital, Turku, Finland.
- Tampere Center for Child Health Research, Tampere University Hospital, Tampere, Finland; Research Unit of Clinical Medicine, Department of Pediatrics, Medical Research Center, Oulu University Hospital and University of…
- PEDEGO Research Unit, Department of Pediatrics, Medical Research Center, Oulu University Hospital and University of Oulu, Oulu, Finland.
- Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland; Research Centre for Integrative Physiology and Pharmacology, and Centre for Population Health Research, InFLAMES Research Flag…
- Immunogenetics Laboratory, Institute of Biomedicine, University of Turku, Turku, Finland.
Förderung
- Academy of Finland
- Sigrid Jusélius Foundation
Zitieren
APA
Ekman, I., Schroderus, A. M., Vuorinen, T., Knip, M., Veijola, R., Toppari, J., Ilonen, J., Lempainen, J., & Kinnunen, T. (2024). The effect of early life cytomegalovirus infection on the immune profile of children. Clinical Immunology. https://doi.org/10.1016/j.clim.2024.110330
Vancouver
Ekman I, Schroderus AM, Vuorinen T, Knip M, Veijola R, Toppari J, et al. The effect of early life cytomegalovirus infection on the immune profile of children. Clinical Immunology. 2024. doi:10.1016/j.clim.2024.110330
BibTeX
@article{Ekman2024,
author = {Ekman, Ilse and Schroderus, Anna-Mari and Vuorinen, Tytti and Knip, Mikael and Veijola, Riitta and Toppari, Jorma and Ilonen, Jorma and Lempainen, Johanna and Kinnunen, Tuure},
title = {The effect of early life cytomegalovirus infection on the immune profile of children},
journal = {Clinical Immunology},
year = {2024},
doi = {10.1016/j.clim.2024.110330}
}
EUVIMED